Although the data still needs to be scrutinized, Quebec company Medicago says its latest trial suggests the COVID-19 vaccine it’s produced with GlaxoSmithKline is showing promise. Jamie Mauracher explains where the Canadian-made shot is now in the approval process, and its implications beyond this country.
Global National
Canadian manufacturer Medicago says its COVID-19 vaccine shows promise in trials
More Videos
-
Humpback whale dies in Nova Scotia river
-
Poilievre looks to Christian voters for support before election
-
Freeland meets with Toronto MPs to discuss byelection loss
-
Canada enacts controversial digital services tax
-
Hurricane Beryl heads for Mexico after pummelling Cayman Islands, Jamaica
-
U.K. election 2024: Brits keep calm and kick Conservatives to the curb, Labour set to win majority
You are viewing an Accelerated Mobile Webpage.
View Original Article